News & Analysis on Clinical Trial Services & Contract Research And Development
News that B-MS has dropped out of an agreement to develop Basulin, an improved formulation of insulin which was the subject of a $165 million deal - including $20 million upfront - between the two companies last year.
Borculo Domo has extended its range of lactose products for pharmaceutical applications with the launch of a new anhydrous version.
Cellomics has launched a new image analysis software module that allows scientists performing drug discovery and basic science research to analyse a broad variety of cell-based assays in as little as five minutes.
Rhodia Pharma Solutions is reducing the workforce at its Dudley site in the UK by up to 85 jobs in a continuing shake-up of the company's custom manufacturing and intermediates business.
Medarex has announced a global collaboration agreement with Pfizer that will provide for the discovery and development of up to 50 antibody products over ten years including the creation of fully human antibody products in a variety of indications...
The world's leading pharmaceutical companies are not doing enough to help improve the health of countries in the third world. They will also be completely unprepared to face the increasing demand for drugs for diseases other than Aids.
A study, which uses immunoglobulins to treat multiple sclerosis, may also be able to help patients with Alzheimer's. The discovery seems to point towards an approach, which treats Alzheimer's with anti-bodies, which are specifically effective against...
Cancer therapy specialists, Ziopharm, has announced it has entered into a licensing agreement for a new class of organic arsenicals with the intention of developing them for a wide range of cancers
A bitter-blocking ingredient developed by Linguagen has been backed for use in foods, beverages and oral pharmaceutical dosage forms by the country's regulatory authorities.